In Chengdu, China, the Indonesia-China Healthcare & Biotech Investment Forum was jointly held by Indonesian Chamber of Commerce and Industry Bilateral Committee for China (KIKT) and Embassy of the Republic of Indonesia (KBRI) on July 27, 2023. During the Forum, Wondfo Biotech and Kimia Farma signed a partnership agreement in the field of in vitro diagnosis. The agreement was signed in the presence of Budi Gunadi Sadikin—Health Minister of Indonesia, H.E Djauhari Oratmangun—Ambassador of Indonesia to China and Arsjad Rasjid—Chairman of Indonesian Chamber of Commerce and Industry.
Kimia Farma (PT Kimia Farma Tbk.) is a state-owned leading pharmaceutical company in Indonesia. It has developed into a company with integrated health service and it has been increasingly engaged in the development and building of the nation.
The partnership agreement will continue to facilitate the collaboration of both side in the field of healthcare and jointly we make contributions in Indonesia. We will also continue our efforts to invest in the public healthcare in Indonesia and to improve the healthcare quality for the Indonesian people.
With 9 technology platforms, Wondfo has been devoted to assisting professional rapid diagnosis and providing comprehensive health management solutions. We aim to make healthcare accessible to more people and make our biology technology benefit the public.
Continuous Efforts in Indonesia
Wondfo Assisted Official Institutions in Improving Healthcare
With our vision to make biology technology benefit the public, Wondfo has been devoted to assisting Indonesian authorities in improving healthcare and make healthcare resources accessible to more people.
In July, 2023. Wondfo and Merck, together with Indonesian Medical Association and Ministry of Health of Indonesia, officially launched national thyroid screening project. In its first phase, it is expected to screen 150 thousand people for thyroid function, reaching Java, Sumatra, Kalimantan, Sulawesi and other major areas.
For the Future of Healthcare
Leveraging Strengths of IVD & Pharmaceutical Enterprises
In February, 2023, Silk Road Fund and Indonesia Investment Agency (INA) announced the successful delivery of the joint investment project of PT Kimia Farma Tbk. (KAEF), a state-owned pharmaceutical pioneer in Indonesia, and PT Kimia Farma Apotek (KFA), a subsidiary of KAEF retailing healthcare materials on e-commerce platform. It is a landmark of cooperation between China and Indonesia under the Belt and Road Initiative.
In May, 2023, Wondfo, together with Silk Road Fund, Indonesia Investment Agency (INA), PT Kimia Farma Tbk and Kimia Farma Apotek, had a discussion about future cooperation in the field of healthcare.
Racing for Life
Wondfo Aims to Make Biology Technology Benefit the Public
During the COVID-19 pandemic, Wondfo donated medical materials to the Coordinating Ministry for Maritime and Investment Affairs Republic of Indonesia for detecting COVID-19. In addition, Wondfo collaborated with Biofarma in the prevention and control of COVID-19 with Wondfo’s RBD Fluorescent Diagnostic Tests, covering over 250 thousand people. In this way, we provide diagnostic products and services to thousands of healthcare institutions and laboratories to safeguard people’s health.
Since Wondfo started international business in 2002, we have been dedicated to facilitate the healthcare in Indonesia and to safeguard people’s health and happiness with our products and services of cutting-edge technology and sound quality.